A purple and pink letter v on a white background.
May 12, 2024

Venus Concept Launches “NEXThetics” Program

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the launch of “NEXThetics”, its new series of customer education and training events. NEXThetics is the newest advancement under the Company’s recent “Venus Aesthetic Intelligence” (or “Venus AI”) rebrand. NEXThetics events also provide professionals from all sectors of the aesthetics industry a networking opportunity to come together and exchange ideas, share success stories, and forge valuable connections.


“As we continue to evolve under the Venus AI banner, we are enhancing our focus on physician education and practice enhancement programs by empowering professionals in the aesthetics field with the knowledge, tools, and support they need for them to thrive. Aesthetic intelligence is not just about our emerging technologies such as robotics or artificial intelligence but about how we shift our focus from device performance to total practice performance,” said Ross Portaro, Executive Vice President, and General Manager, Global Sales and Marketing. “This transition requires focusing on how we educate and train attendees on all aspects of running a successful practice, leveraging our technologies and services to grow their businesses.”


During NEXThetics events, attendees can experience live demonstrations led by top physicians, showcasing the effectiveness and versatility of Venus devices and services. Over the last four months, the Company hosted several pilot events in Dallas, Miami, Toronto, and Atlanta, which have been well received by customers and industry professionals. In these events, leading industry luminaries including Dr. Scott Gerrish, Dr. Gilly Munavalli and others shared their hands-on experience with the audience, presented success stories, and discussed other elements that are essential in building a successful practice, such as marketing programs, customer service, and post treatment care.


“In 2024, we are looking to continue building on the success of our pilot NEXThetics events and drive innovation and education within aesthetics and hair restoration. Our NEXThetics program is another platform we offer to our customers that will elevate their practice and help them stay ahead of the curve,” explained Hemanth Varghese, President & Chief Operating Officer of Venus Concept.


The next upcoming NEXThetic events will be held in early-June in Cleveland, Ohio and New York City, New York.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.